These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date Terminated 2017-000589-31 multi stage phase II trial of Nivolumab (an anti –PD-1) in patients with platinum resistant Mismatch Repair deficient germinal cells tumours Studio di fase II multi step sul Nivolumab (un anti-PD-1... bad-data
Ongoing 2017-003739-12 Preoperative Nivolumab in patients with locally advanced colon cancer (T3 or T4): a window-of-opportunity study Nivolumab preoperatorio in pazienti con cancro al colon localmente avanzato (T3 o T4)... not-yet-due